Javier, Esterlita L.

HRN: 03-08-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/27/2023
10/03/2023
IV
4.5g
Q6
Abscess
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: